CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

OSL:CONTX • SE0014731154

3 NOK
+0.03 (+1.01%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CONTX. CONTX was compared to 11 industry peers in the Health Care Technology industry. Both the profitability and the financial health of CONTX get a neutral evaluation. Nothing too spectacular is happening here. CONTX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CONTX had positive earnings in the past year.
  • CONTX had a positive operating cash flow in the past year.
  • Of the past 5 years CONTX 4 years were profitable.
  • In the past 5 years CONTX always reported a positive cash flow from operatings.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets of 0.61%. This is comparable to the rest of the industry: CONTX outperforms 54.55% of its industry peers.
  • CONTX's Return On Equity of 0.83% is in line compared to the rest of the industry. CONTX outperforms 54.55% of its industry peers.
  • CONTX has a Return On Invested Capital (0.30%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 8.07%.
  • The last Return On Invested Capital (0.30%) for CONTX is well below the 3 year average (20.44%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROIC 0.3%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.69%, CONTX is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • CONTX's Profit Margin has declined in the last couple of years.
  • CONTX has a Operating Margin (0.36%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CONTX has declined.
  • With an excellent Gross Margin value of 97.37%, CONTX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • CONTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
  • Compared to 1 year ago, CONTX has a worse debt to assets ratio.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • The Debt to FCF ratio of CONTX is 62.32, which is on the high side as it means it would take CONTX, 62.32 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CONTX (62.32) is comparable to the rest of the industry.
  • CONTX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • CONTX has a Debt to Equity ratio of 0.10. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Altman-Z N/A
ROIC/WACC0.04
WACC6.99%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.28. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX has a Current ratio of 4.28. This is amongst the best in the industry. CONTX outperforms 90.91% of its industry peers.
  • CONTX has a Quick Ratio of 4.23. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.23, CONTX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.23
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.77%.
  • CONTX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -41.36% yearly.
  • The Revenue for CONTX has decreased by -15.61% in the past year. This is quite bad
  • Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%

3.2 Future

  • Based on estimates for the next years, CONTX will show a very strong growth in Earnings Per Share. The EPS will grow by 400.00% on average per year.
  • CONTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.70% yearly.
EPS Next Y1200%
EPS Next 2Y400%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.66%
Revenue Next 2Y3.7%
Revenue Next 3Y6.52%
Revenue Next 5Y2.7%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 300.00, which means the current valuation is very expensive for CONTX.
  • Compared to the rest of the industry, the Price/Earnings ratio of CONTX is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (27.13), we can say CONTX is valued expensively.
  • CONTX is valuated quite expensively with a Price/Forward Earnings ratio of 25.19.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CONTX is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of CONTX to the average of the S&P500 Index (28.11), we can say CONTX is valued inline with the index average.
Industry RankSector Rank
PE 300
Fwd PE 25.19
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • CONTX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CONTX is more expensive than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1093.27
EV/EBITDA N/A
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CONTX may justify a higher PE ratio.
  • A more expensive valuation may be justified as CONTX's earnings are expected to grow with 400.00% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y400%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
  • The stock price of CONTX dropped by -28.06% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.31. CONTX pays more dividend than 81.82% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CONTX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y400%
EPS Next 3YN/A
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTEXTVISION AB

OSL:CONTX (2/27/2026, 7:00:00 PM)

3

+0.03 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19
Earnings (Next)05-08
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap232.11M
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Analysts40
Price Target4.08 (36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.74%
Valuation
Industry RankSector Rank
PE 300
Fwd PE 25.19
P/S 2
P/FCF 1093.27
P/OCF 49.73
P/B 2.4
P/tB 2.46
EV/EBITDA N/A
EPS(TTM)0.01
EY0.33%
EPS(NY)0.12
Fwd EY3.97%
FCF(TTM)0
FCFY0.09%
OCF(TTM)0.06
OCFY2.01%
SpS1.5
BVpS1.25
TBVpS1.22
PEG (NY)0.25
PEG (5Y)N/A
Graham Number0.53
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROCE 0.39%
ROIC 0.3%
ROICexc 0.96%
ROICexgc 1.03%
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
FCFM 0.18%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
ROICexc(3y)77.73%
ROICexc(5y)111.49%
ROICexgc(3y)103.93%
ROICexgc(5y)184.88%
ROCE(3y)26.61%
ROCE(5y)48.75%
ROICexgc growth 3Y-81.88%
ROICexgc growth 5Y-66.49%
ROICexc growth 3Y-79.52%
ROICexc growth 5Y-59.81%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.84%
Interest Coverage 0.99
Cash Conversion N/A
Profit Quality 26.51%
Current Ratio 4.28
Quick Ratio 4.23
Altman-Z N/A
F-Score5
WACC6.99%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.73%
Cap/Sales(5y)4.01%
Profit Quality(3y)87.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
EPS Next Y1200%
EPS Next 2Y400%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%
Revenue Next Year5.66%
Revenue Next 2Y3.7%
Revenue Next 3Y6.52%
Revenue Next 5Y2.7%
EBIT growth 1Y-98.68%
EBIT growth 3Y-78.36%
EBIT growth 5Y-61.27%
EBIT Next Year3400%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.31%
FCF growth 3Y-78.75%
FCF growth 5Y-57.02%
OCF growth 1Y-86.52%
OCF growth 3Y-44.44%
OCF growth 5Y-27.59%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 5 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to grow by 1200% in the next year.